This review distils the essential information regarding transcatheter aortic valve replacement from the 2017 ESC/EACTS guidelines on the management of valvular heart disease.
This review provides a concise summary of the 2017 ESC/EACTS guideline updates on the indications for transcatheter aortic valve replacement.
New European guidelines on the management of valvular heart disease-supported by the European Society of Cardiology (ESC) and European Association of CardioThoracic Surgery (EACTS)-were recently published. Although these guidelines are very comprehensive, these typically are not very inviting to read. In this document, we aimed to distil all the information about transcatheter aortic valve replacement (TAVR) in the new 2017 ESC/EACTS guidelines to the essential and give additional comments on the position of TAVR in 2017.
Thonghong et al. (Thu,) conducted a review in Valvular heart disease. Transcatheter aortic valve replacement (TAVR) guidelines was evaluated. This review distils the essential information regarding transcatheter aortic valve replacement from the 2017 ESC/EACTS guidelines on the management of valvular heart disease.